中文摘要:
泡沫巨噬細(xì)胞的積累是脫髓鞘腦疾病的病理特征。代謝紊亂和細(xì)胞內(nèi)脂質(zhì)的外排是這些疾病中有害的泡沫巨噬細(xì)胞表型發(fā)展的根本原因,但其背后的分子機(jī)制尚不明確。在這里,我們展示了泛素-蛋白酶體系統(tǒng)控制大腦中脂質(zhì)負(fù)荷巨噬細(xì)胞的膽固醇外排轉(zhuǎn)運(yùn)蛋白ATP結(jié)合盒A1(ABCA1)的周轉(zhuǎn)。我們報(bào)告說,髓鞘衍生脂質(zhì)的積累促進(jìn)了巨噬細(xì)胞中泛素-蛋白E3連接酶A(UBE3A)的豐度和活性,這刺激了ABCA1的泛素化及隨后的降解。這增加了細(xì)胞脂質(zhì)的積累并誘導(dǎo)了損害再髓鞘化的炎性巨噬細(xì)胞表型。我們進(jìn)一步確定參與Tat的蛋白30(TIP30),作為介導(dǎo)進(jìn)口蛋白β的核內(nèi)導(dǎo)入的抑制劑,是細(xì)胞質(zhì)UBE3A水平的一個(gè)重要調(diào)節(jié)因子。總之,我們的發(fā)現(xiàn)將UBE3A確定為泡沫細(xì)胞形成的驅(qū)動(dòng)因素,并表明靶向UBE3A介導(dǎo)的ABCA1降解是增強(qiáng)中樞神經(jīng)系統(tǒng)修復(fù)的一個(gè)有前景的策略。
英文摘要:
The accumulation of foamy macrophages is a pathological hallmark of demyelinating brain disorders. Perturbed metabolism and efflux of intracellular lipids underlie the development of a harmful foamy macrophage phenotype in these disorders, yet, the molecular mechanisms underlying this dysregulation are poorly understood. Here, we show that the ubiquitin-proteasome system controls the turnover of the cholesterol efflux transporter ATP-binding cassette A1 (ABCA1) in lipid-loaded macrophages in the brain. We report that accumulation of myelin-derived lipids promotes the abundance and activity of ubiquitin-protein E3 ligase A (UBE3A) in macrophages, which stimulates ABCA1 ubiquitination and subsequent degradation. This boosts cellular lipid accumulation and induces an inflammatory macrophage phenotype that impairs remyelination. We further establish Tat-interacting protein 30 (TIP30), an inhibitor of importin β-mediated nuclear import, as an essential regulator of cytosolic UBE3A levels. Together, our findings identify UBE3A as a driver of foam cell formation and indicate that targeting UBE3A-mediated ABCA1 degradation is a promising strategy to enhance central nervous system repair.
論文信息:
論文題目:UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation
期刊名稱:Nature Communications
時(shí)間期卷:16, Article number: 8077 (2025)
在線時(shí)間:2025年8月29日
DOI:doi.org/10.1038/s41467-025-62053-w
產(chǎn)品信息:
貨號:CP-005-005
規(guī)格:5ml+5ml
品牌:Liposoma
產(chǎn)地:荷蘭
名稱:Clodronate Liposomes and Control Liposomes
辦事處:Target Technology(靶點(diǎn)科技)
Clodronate Liposomes氯膦酸鹽脂質(zhì)體清除泡沫巨噬細(xì)胞,泡沫巨噬細(xì)胞含有過量的細(xì)胞內(nèi)來源于髓鞘的脂質(zhì),導(dǎo)致多發(fā)性硬化癥(MS)等神經(jīng)退行性疾病的病理。雖然對富含脂質(zhì)的結(jié)構(gòu),如改良的脂蛋白和髓鞘的攝取,將巨噬細(xì)胞表型重塑為通常與組織修復(fù)和免疫抑制相關(guān)的表型,但這種解決疾病的表型僅是短暫的。我們和其他研究者發(fā)現(xiàn),巨噬細(xì)胞中髓鞘來源脂質(zhì)的過度積累,尤其在衰老過程中,使泡沫細(xì)胞傾向于更具炎癥性和促進(jìn)疾病的表型。這種有害表型的誘導(dǎo)與大腦修復(fù)模型中損傷恢復(fù)受損密切相關(guān)。從機(jī)制上講,細(xì)胞內(nèi)脂質(zhì)的新陳代謝失調(diào),主要由于膽固醇外流減少,導(dǎo)致細(xì)胞脂質(zhì)含量失衡和有害泡沫巨噬細(xì)胞亞群的發(fā)展。荷蘭Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes見刊于Nature Communications:氯膦酸鹽脂質(zhì)體clodronateliposomes體外清除腦切片Cerebellar brain slices 巨噬細(xì)胞。
Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體體外清除腦切片巨噬細(xì)胞的材料和方法:
腦切片體外巨噬細(xì)胞清除材料和方法文獻(xiàn)截圖:
靶點(diǎn)科技(北京)有限公司
地址:中關(guān)村生命科學(xué)園北清創(chuàng)意園2-4樓2層
© 2025 版權(quán)所有:靶點(diǎn)科技(北京)有限公司 備案號:京ICP備18027329號-2 總訪問量:341849 站點(diǎn)地圖 技術(shù)支持:化工儀器網(wǎng) 管理登陸